Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lyrica. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step route for Pregabalin avoids resolution waste. High ee value up to 99.6%. Cost-effective manufacturing for pharma intermediates.
Patent CN105367434A details isobutyraldehyde route for pregabalin. Ensures high purity and supply chain stability for global pharmaceutical manufacturing needs.
Novel patent CN105061234A offers high-purity pregabalin route. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN101585778A details a scalable route from S-(+)-leucine avoiding toxic azides. Ideal for reliable lyrica intermediate supplier sourcing and cost reduction.
Patent CN103073443B details a novel asymmetric synthesis for Pregabalin, offering improved yield and scalability for pharmaceutical supply chains.